Cargando…
Reticular corneal epithelial edema with topical netarsudil
Rho-associated protein kinase inhibitor (ROCK) therapy for corneal endothelial dysfunction or damage other than glaucoma has been reported with few ocular side effects. We report reticular epithelial edema (REE) with netarsudil (0.02%) therapy in four cases with different clinical scenarios (three c...
Autores principales: | Parmar, Dipali P., Bhole, Pradnya K., Garde, Pawan V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062072/ https://www.ncbi.nlm.nih.gov/pubmed/37007228 http://dx.doi.org/10.4103/ojo.ojo_2_22 |
Ejemplares similares
-
Netarsudil-associated reticular corneal epithelial edema
por: Tran, Jennifer A., et al.
Publicado: (2022) -
Two pediatric cases of reticular corneal epithelial edema associated with netarsudil
por: Guzman Aparicio, Maria A., et al.
Publicado: (2022) -
Acute graft rejection in a high-risk corneal transplant following COVID-19 vaccination: A case report
por: Parmar, Dipali P, et al.
Publicado: (2021) -
Anterior segment optical coherence tomography features of netarsudil-associated reticular corneal edema
por: Khalili, Ashley, et al.
Publicado: (2022) -
Netarsudil-associated epithelial keratopathy
por: Ramakrishnan, Meera S., et al.
Publicado: (2020)